Platform Technology

Development of drug delivery platforms that enhance both treatment convenience
and therapeutic efficacy

We are developing Next-generation delivery platforms that improve drug delivery efficiency
and sustain in vivo exposure, enabling a more patient-centric treatment experience.

Pipeline

Modality

Indication

Development Stage

IDC224

SC Platform

Breast cancer

PoC

IDC225

Ocular Platform

Undisclosed

Discovery

IDC226

SC Platform

Arthritis

PoC

IDC227

TASA™ Platform

Universal

PoC

Pipeline

IDC224
Modality Indication
SC Platform Breast cancer
Development Stage
PoC

Pipeline

IDC225
Modality Indication
Ocular drug delivery Platform Undisclosed
Development Stage
Discovery

Pipeline

IDC226
Modality Indication
SC Platform Arthritis
Development Stage
PoC

Pipeline

IDC227
Modality Indication
TASA™ Universal
Development Stage
PoC